ABVC BioPharma, Inc. (ABVC) vs TherapeuticsMD, Inc. (TXMD)

A side-by-side comparison of ABVC BioPharma, Inc. and TherapeuticsMD, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ABVC vs TXMD

growth of $100 · dividends reinvested · last 10y
ABVC -99.7% (-44.6%/yr)TXMD -99.4% (-40.0%/yr)TXMD compounded faster over this window
050100Start $10020182020202220242026$0$1
ABVC TXMD

ABVC vs TXMD: by the numbers

  • •ABVC is the larger company ($24M vs $23M market cap).
  • •Both run net losses; ABVC's is the smaller (0.00% vs -6.64% net margin).

Metrics side by side

Valuation

MetricABVCTXMD
Forward P/EN/A11.76
P/S ratioN/A7.08
P/B ratio2.350.85
FCF yieldN/A13.48%

Profitability

MetricABVCTXMD
Gross margin0.00%100.00%
Operating margin0.00%-139.44%
Net margin0.00%-6.64%
ROE-76.82%-0.80%
ROIC-53.34%-11.84%

Growth (annualized)

MetricABVCTXMD
Revenue CAGR (5Y)N/A-47.86%
Total return CAGR (5Y)-46.33%-44.16%

Frequently asked

How have ABVC and TXMD total returns compared?
Over the past 10 years, ABVC delivered -44.60% and TXMD delivered -40.05% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.